WADA allows Ozempic, Mounjaro use under 2027 anti-doping rules

 WADA allows Ozempic, Mounjaro use under 2027 anti-doping rules

WADA’s newly updated anti-doping regulations now permit athletes to continue utilizing weight-loss drugs Ozempic and Mounjaro, as they are included in the monitored category rather than prohibited. As research progresses into their significant physiological i…

View All Comments
Share your thoughts in the comments
Be respectful · TOI community guidelines